- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Handa Pharmaceuticals (6620)
Handa Pharmaceuticals stock price live, this page displays TWO 6620 stock exchange data. View the 6620 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Handa Pharmaceuticals real time stock price chart below.
What Is the Handa Pharmaceuticals Stock Price Today?
The Handa Pharmaceuticals stock price today is 81.90.
What Is the Stock Symbol for Handa Pharmaceuticals?
The stock symbol for Handa Pharmaceuticals is ""6620.""
What Stock Exchange Does Handa Pharmaceuticals Trade On?
Handa Pharmaceuticals is listed and trades on the TPEX stock exchange.
Is Handa Pharmaceuticals a Good Stock to Buy?
Determining whether Handa Pharmaceuticals—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6620 quote. (ISIN: TW0006620008)
What Is the Handa Pharmaceuticals Stock Price Today?
The Handa Pharmaceuticals stock price today is 81.90.
What Is the Stock Symbol for Handa Pharmaceuticals?
The stock symbol for Handa Pharmaceuticals is ""6620.""
What Stock Exchange Does Handa Pharmaceuticals Trade On?
Handa Pharmaceuticals is listed and trades on the TPEX stock exchange.
Is Handa Pharmaceuticals a Good Stock to Buy?
Determining whether Handa Pharmaceuticals—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6620 quote. (ISIN: TW0006620008)
TPEX
Currency in TWD
81.90
0.00(0.00%)
Delayed Data·
Fair Value
An estimate of a Handa Pharmas's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
80.50
82.30
52 wk Range
49.90
95.40
6620 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
6620 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Handa Pharmas's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
80.5082.30
52 wk Range
49.9095.40
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.84%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.84%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6620 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Handa Pharmas's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
200.00
Upside
+144.20%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Handa Pharmaceuticals Company Profile
Handa Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of drugs for various diseases in the United States. The company offers ONCORE, a proprietary drug delivery technology that was developed to improve the patient compliance and safety of the tyrosine kinase inhibitor of oncology drugs; Tascenso ODT for the treatment of multiple sclerosis; and HND-033, HND-039, and HND-027 for oncology diseases. It also provides Quetiapine XR to treat Schizophrenia; Dexlansoprazole DR capsules to treat erosive esophagitis and heartburn associated with symptomatic non-erosive gastroesophageal reflux disease; HND-004 for treating diabetes; HND-032 for smoking cessation; and HND-026, a GI drug. Handa Pharmaceuticals, Inc. was founded in 2014 and is headquartered in Tainan City, Taiwan.
Compare 6620 to Peers and Sector
Metrics to compare | 6620 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6620PeersSector | |
|---|---|---|---|---|
P/E Ratio | 27.4x | 0.0x | −0.5x | |
PEG Ratio | −0.72 | 0.00 | 0.00 | |
Price/Book | 4.2x | 0.0x | 2.6x | |
Price / LTM Sales | 15.6x | 0.0x | 3.3x | |
Upside (Analyst Target) | 144.2% | 0.0% | 43.3% | |
Fair Value Upside | Unlock | 0.0% | 6.9% | Unlock |
Analyst Ratings
1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 200.00
(+144.20% Upside)
Earnings
Latest Release
Apr 29, 2025
EPS / Forecast
1.79 / 8.91
Revenue / Forecast
397.77M / 1.402B
FAQ
What Stock Exchange Does Handa Pharmas Trade On?
Handa Pharmas is listed and trades on the Taipei Exchange stock exchange.
What Is the Stock Symbol for Handa Pharmas?
The stock symbol for Handa Pharmas is "6620."
What Is the Handa Pharmas Market Cap?
As of today, Handa Pharmas market cap is 12.97B.
What Is Handa Pharmas's Earnings Per Share (TTM)?
The Handa Pharmas EPS (TTM) is 3.37.
From a Technical Analysis Perspective, Is 6620 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Handa Pharmas Stock Split?
Handa Pharmas has split 2 times.
How Many Employees Does Handa Pharmas Have?
Handa Pharmas has 0 employees.
What is the current trading status of Handa Pharmas (6620)?
As of 11 Aug 2025, Handa Pharmas (6620) is trading at a price of 81.90, with a previous close of 86.50. The stock has fluctuated within a day range of 80.50 to 82.30, while its 52-week range spans from 49.90 to 95.40.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.